Aravive, Inc. — Form D

Aravive, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2013-07-22. The offering totals $12.5M, of which $12.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (27)

Showing 25 of 27 people.

NameRoleLocation
JEFFREY CLELANDDirectorBALTIMORE, MD
JEFFREY CLELANDExecutive OfficerBALTIMORE, MD
Shahzad MalikDirectorSan Diego, CA
Michael DybbsDirectorHalf Moon Bay, CA
Srinivas AkkarajuDirectorPalo Alto, CA
Fredric N EshelmanDirectorDurham, NC
Fredric N EshelmanExecutive OfficerDurham, NC
Kevin JohnsonDirectorSan Diego, CA
MICHAEL W ROGERSDirectorNEW YORK, NY
Francesco De RubertisDirectorCharlottesville, VA
Anthony SunDirectorApex, NC
Jay ShepardDirectorDallas, TX
Rudy N HowardExecutive OfficerHouston, TX
Sigurd C KirkDirectorHouston, TX
Peter TC HoDirectorHouston, TX
Robert B GellerExecutive OfficerHouston, TX
Gail McIntyreDirectorHouston, TX
Gail McIntyreExecutive OfficerHouston, TX
Leonard Scott DoveExecutive OfficerHouston, TX
Eric B ZhangDirectorHouston, TX
Amato B GiacciaDirectorHouston, TX
John A HohneckerDirectorHouston, TX
Volker SchellenbergerDirectorSouth San Francisco, CA
Joshua BrummExecutive OfficerWaltham, MA
Edmon JenningsDirectorRedwood City, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2022-10-28D$41.6M$41.6M
2014-02-20D$55.0M$55.0M
2014-02-19D$10.0M$10.0M
2013-10-11D$10.0M$10.0M
2013-01-28D$20.5M$8.0M
2013-01-28D$4.6M$4.6M
2011-03-09D$21.1M$14.4M

More